Evaluation study of the efficacy of preoperative hormone therapy for localized prostate cancer.

Evaluation study of the efficacy of preoperative hormone therapy for localized prostate cancer. - Evaluation study of the efficacy of preoperative hormone therapy for localized prostate cancer.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000053867

Enrollment

100

Registered

2024-03-14

Start date

2022-12-21

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate cancer

Interventions

Hormone therapy No hormone therapy

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Patients planned to be treated with preoperative hormone therapy followed by total prostatectomy who agreed to participate in the study.

Exclusion criteria

Exclusion criteria: Patients younger than 20 years old Patients who could not agree to this study

Design outcomes

Primary

Measure	Time frame
PSA progression-free survival (PSA-PFS)	—

Secondary

Measure	Time frame
Rate of positive margins in surgically removed prostates, Overall survival (OS), adverse events, surgical outcomes (operation time, perioperative complications, etc.), comorbidities, various patient backgrounds, blood draw data, imaging data, pathological data	—

Countries

Japan

Contacts

Public ContactTaiki Kamijima

Department of Integrative Cancer Therapy and Urology Department of Integrative Cancer Therapy and Urology

kamiji0029@yahoo.co.jp076-265-2000

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026